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Noroviruses were detected in 48.4% of 192 children 
(<3 years of age) hospitalized for gastroenteritis in Palermo, 
Italy, during 2004; predominant genotypes were GGIIb/Hil-
versum and GGII.4 Hunter. Of children with viral enteritis, 
19.6% had a mixed norovirus-rotavirus infection. The sever-
ity of infection was lower for norovirus than for rotavirus but 
increased in co-infection.
N
oroviruses (NoVs) were the ﬁ  rst viruses to be clearly 
associated with acute gastroenteritis, but for many 
years, knowledge of their role in infection and disease has 
been limited (1). The introduction of the reverse transcrip-
tion–PCR (RT-PCR) method deﬁ  ned the relevant role of 
these agents in outbreaks and sporadic cases of gastroen-
teritis throughout the world and showed the broad hetero-
geneity and rapid evolution of NoV strains (2–5). 
Italy has no surveillance system for nonbacterial gas-
troenteritis. Recently 2 outbreaks of conﬁ  rmed NoV gas-
troenteritis were reported (6,7). With regard to sporadic 
enteritis in Italian children, the few studies performed have 
reported prevalence rates from 2.1% to 18.6 % (8–11). 
The Study 
This report aims to describe the clinical and epidemio-
logic features of NoV infection in children hospitalized for 
enteritis and to compare the severity score related to the 
different viral agents and NoV genotypes. From January to 
December 2004, 390 fecal specimens were obtained from 
365 children with acute gastroenteritis within 24 hours of 
admission to the Department of Infectious Diseases at the G. 
Di Cristina Children’s Hospital in Palermo, Italy. Gastroen-
teritis was deﬁ  ned as >3 stools that were looser than normal 
stools per day or 1 episode of vomiting. Demographic and 
clinical data were collected for most patients. A 14-point 
scoring system was used to summarize the clinical severity 
of the cases (Table 1). All the specimens were examined 
for the presence of Salmonella spp., Shigella spp., Campy-
lobacter spp., and Yersinia spp. One hundred ninety-nine 
samples negative for bacteria and from 192 children (100 
boys and 92 girls; median age 11.75 months) were exam-
ined for NoVs, group A rotaviruses (HRVs), adenoviruses 
(AdVs), and astroviruses (HAstVs). NoV detection was 
carried out by single-step or nested RT-PCR (12). Positive 
and negative controls were included in all ampliﬁ  cation re-
actions, and contamination of reactions by PCR products 
was avoided by strict separation of working areas and the 
use of ﬁ  lter-plugged pipette tips. The genotyping of NoV 
strains was obtained by sequence analysis performed on the 
RNA-dependent RNA polymerase gene and the sequences 
were aligned and compared with a selection of representa-
tive sequences from the various NoV genotypes available 
in online databases (12).
HRV, AdV, and HAstV were detected by enzyme im-
munoassays (EIAs) (IDEIA Rotavirus, IDEIA Adenovirus, 
and Ampliﬁ  ed IDEIA Astrovirus; DakoCytomation, An-
gel Drove, UK). AdV-positive specimens were tested for 
enteric subgenus F serotypes 40 and 41 with the Premier 
Adenoclone-type 40–41 EIA (EIA Cambridge Bioscence, 
Worcester, MA, USA). HAstV-positive samples were con-
ﬁ  rmed by RT-PCR (10). Statistical analysis was carried 
out by using the χ2 test, and a signiﬁ  cance level of 5% was 
adopted.
NoVs were detected in 93 (48.4%) of 192 patients, 
and at least 1 of the gastroenteric viruses tested was found 
in 148 (77.1%) patients. Among 148 patients positive 
for enteric viruses, NoVs were the only viruses detected 
in 58 (39.2%), while 1 or 2 more viruses were present in 
35 (23.6%) (Table 2). Of the 93 NoVs-positive patients, 
74 (79.6%) were detected after the ﬁ  rst PCR step, and 
19 (20.4%) after the nested-PCR step. A total of 36 RT-
PCR amplicons, 28/74 ﬁ  rst step–positive and 8/19 nested-
positive, were submitted for sequencing.  
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Table 1. Clinical parameters for evaluating gastroenteritis severity 
and related score 
Clinical parameter/value  Score
Duration of diarrhea, d 
 <2  1
 2–4  2
 >4  3
Maximum no. bowel movements/d 
 3 
 4–5  2
 >5  3
Duration of vomiting, d 
 No  vomiting  0
 1–2    1
 >2  3
Fever 
 No  0
 Yes  2 
Intravenous rehydration 
   No  0
 Yes  3 DISPATCHES
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HRVs were identiﬁ  ed in 80 (41.6%) of 192 patients, 
AdVs in 8 (4.2%) patients, with 1 (0.5%) strain belong-
ing to serotype 40/41, and HAstVs in 5 (2.6%) patients. 
Overall, single viral infections were found in 112 (58.3%) 
of 192 patients; double viral infections were detected in 34 
(17.7%) patients, and 2 (1%) patients were infected with 3 
viral agents. 
All the NoV strains sequenced were characterized 
as GGII NoVs and could be attributed to a deﬁ  ned geno-
type. The 2 predominant strains were GGIIb/Hilversum 
(44.4%) and GGII.4 Hunter (52.8%); a single strain be-
longed to the GGII.4 Farmington Hills cluster. Both the 
GGIIb/Hilversum- and the GGII.4-positive patients were 
also infected with another virus in 37.5% and 35% of 
cases, respectively. 
NoV infections were detected in almost every month of 
the year; the highest incidence was recorded from February 
through May. Most of the GGIIb/Hilversum strains were 
isolated from February through April; the GGII.4 strains 
were detected at a higher frequency from January through 
March and again from October through December.   
Children infected by NoVs comprised 46 (49.5%) 
boys and 47 (50.5%) girls. The median age was 12 months. 
The median duration of diarrhea was 4 days (range 1–17 
days) with a median  number of bowel movements per day 
of 7.5 (range 1–21). Vomiting and fever were present in 46 
(49.5%) and 48 (51.6%) children, respectively. Thirty nine 
(41.9%) children showed signs of dehydration. There was 
no clinical difference in the median age and in the severity 
of illness caused by each of the 2 prevalent NoV genotypes 
(p>0.05). 
The severity score in all the groups of infected children 
is shown in Table 2. Though not statistically signiﬁ  cant 
(p>0.05), HRVs were associated with the highest severity 
score among single infections. The severity score for NoV 
co-infections was higher than that for NoV single infec-
tions, except for double infections with HAstV. In the last 
few years many studies have conﬁ  rmed the growing im-
portance of NoVs as agents of sporadic enteritis. In Italy, 
the NoV detection rate in pediatric enteritis appears to be 
increasing. In 2002 in northern Italy, RT-PCR found NoVs 
to be the second most common viral agents of enteritis after 
HRVs, with a rate of 10.4% of single infections (11). In our 
study, NoVs emerged as the principal cause of viral en-
teritis (p<0.05) responsible for 39.2% of cases of diarrhea 
positive for at least 1 viral agent. 
The 2 predominant NoV genotypes circulating in 
southern Italy in 2004 were GGII.4 Hunter and GGIIb/
Hilversum. The ﬁ   rst was identiﬁ   ed in Australia during 
2002–2004 and was then related to  an increase in gastro-
enteritis outbreaks in the Netherlands; the second appeared 
in France in 2000 and soon became prevalent in Europe 
(3,4,13). GGIIb/Hilversum has been described as a strain 
highly prone to recombinational events, and it may play a 
peculiar role in children (3,14). Detection of both GGII.4 
and GGIIb/Hilversum NoV genotypes in sporadic cases of 
gastroenteritis occurring throughout the year in our area 
demonstrates that 2 distinct NoV strains can be introduced 
in a local population and be maintained over a long period. 
Emergence of new genetic variants may be the cause of 
increasing NoV infections (5). 
Conclusions 
Our results highlight the need to apply molecular diag-
nostic tools widely to determine the actual etiology of acute 
childhood enteritis when the causative agent is not known. 
This procedure enabled us to deﬁ  ne the real prevalence of 
NoV infection and its frequent occurrence in association 
with another etiologic agent (18.2%), as reported (2,11). 
The protracted duration of virus shedding reported both in 
HRV and NoV infections makes it difﬁ  cult to attribute the 
main clinical role to one or the other as either may well rep-
resent asymptomatic shedding after an early infection (15). 
The lower severity score observed in NoV single infections 
with regard to both NoV-HRV mixed infections and HRV 
single infections, suggests that the clinical picture might be 
dominated by HRVs. However, both viruses could be act-
ing in synergy, and this option might also be contemplated 
for NoV-AdV co-infections because their score was higher 
than that of single infections with each of the 2 viruses. 
To our knowledge, this is the ﬁ  rst report relating the clini-
cal picture to NoV genotypes. This study did not show any 
statistically signiﬁ  cant difference in the clinical parameters 
evaluated in patients infected with GGII.4 or GGIIb/Hil-
versum types (p>0.05).
In conclusion, NoVs emerged in our area as the main 
cause of sporadic viral gastroenteritis in hospitalized chil-
dren during 2004, reaching epidemiologic effects of HRV. 
Analysis of the genetic variability of NoV permitted con-
ﬁ  rmation of the changing epidemiologic features of these 
emerging pathogens. 
Table 2. Severity score of 148 cases of infantile viral 
gastroenteritis related to their etiology* 
Infection No. cases (%) 
Median severity 
score 
NoV 58 (39.2) 8
HRV 50 (33.8) 10
AdV 4 (2.7) 8
NoV-HRV 27 (18.2) 10.5
NoV-AdV 3 (2) 10
NoV-HAstV 3 (2) 8
NoV-HRV-HAstV 2 (1.4) 14
HRV-AdV 1 (0.7) ND
*NoV, norovirus; HRV, rotavirus; AdV, adenovirus; HAstV, astrovirus; ND, 
not determined.  Norovirus in Hospitalized Children, Italy
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